Study of EVO756 in Adults With Migraine

Recruiting now · Phase 2 · Has a placebo group

Conditions studied: Migraine

In brief

This study will evaluate the efficacy and safety of EVO756 against placebo in adults with migraine.

Key facts

Study ID

NCT07616128

Run by

Evommune, Inc.

People needed

330

Starts

2026-06-01

Expected to finish

2027-11-01

Last updated by the study team

2026-07-01

Who can join

Age: 18 and older, up to 64. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Clinical Neuroscience Solutions, Inc. — Orlando, Florida, United States (enrolling)
• Eximia Research NC — Raleigh, North Carolina, United States (enrolling)
• Clinical Trials of South Carolina — Charleston, South Carolina, United States (enrolling)
• FutureSearch Trials of Neurology — Austin, Texas, United States (enrolling)
• FutureSearch Trials of Dallas — Dallas, Texas, United States (enrolling)
• Clinical Neuroscience Solutions, Inc. — Jacksonville, Florida, United States (enrolling)
• Clinosis - Dent Neurologic Instite — Amherst, New York, United States
• CA Medical Clinic for Headache — Los Angeles, California, United States
• Vaught Neurological Services — Crab Orchard, West Virginia, United States
• New England Institute for Neurology and Headache — Stamford, Connecticut, United States
• Apple Medical Research Group, Inc — Miami, Florida, United States
• Vantage Clinical Trials — Tampa, Florida, United States
• Accel Research Site-Decatur-Alcanza — Decatur, Georgia, United States
• Michigan Headache and Neurological Institute — Ann Arbor, Michigan, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.